Clinical Trials Browser

Phase 2 × Endometrial Adenocarcinoma × Gemcitabine × Clear all

NCT00820898 2017-12-29

Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 2 Completed

24 enrolled 7 charts

Endometrial Adenocarcinoma